Cicletanine
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00832507)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ncc2c(c1O)COC2c1ccc(Cl)cc1- Mol. weight
- 261.71 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL191886 ↗
Also known as
- 1,3-dihydro-6-methyl-7-hydroxy-3-(4-chlorophenyl)furo(3,4-d)pyridine
- (+/-)bn-1270
- (+/-)bn-1270
- bn 1270
- bn-1270
- cicletanide
- cicletanide
- cicletanine
- cicletanine
- cicletanine
- cicletanine
- cicletanine
- cicletanine
- cicletanine
- cicletanine
- (+/-)-cicletanine
- cicletanine hydrochloride
- cycletanide
- cycletanide
- justar
- tenstaten
- win-90000
- win-90000
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02709031 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2016 | Indiclinica, Navitas Pharma |
| NCT00832507 | Phase 2 | Jan 1, 2009 | Gilead Sciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gilead Sciences | For profit | 1 | 1 | 1 | 2009 |
| Indiclinica | For profit | 1 | 0 | 1 | 2016 |
| Navitas Pharma | For profit | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1